Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE)
2020-001209-22Phase 3Unknown
- Sponsor
- University of Oxford
- Start
- Mar 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hydroxychloroquine, azithromycin, doxycycline and budesonide in coronavirus disease 2019 (COVID-19) (5 arms), sponsored by University of Oxford. Primary endpoint: Hospital admission or mortality related to suspected COVID-19. Status: unknown.
02
Drugs
hydroxychloroquineazithromycindoxycyclinebudesonide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001209-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001209-22.